SlideShare a Scribd company logo
1 of 53
CERVICAL CANCER
FAHAD ZAKWAN
Review of anatomy
Epidemiology
• Cancer of the cervix uteri is the second most
common cancer among women worldwide
BUT
• for Tanzania is the leading type of cancer in
women and the commonest cause of cancer
related deaths in this country.
Burden in Tanzania
• Tanzania has a population of 10.97 millions women ages 15
years and older who are at risk of developing cervical cancer.
• Current estimates indicate that every year 6241 women are
diagnosed with cervical cancer and 4355 die from the disease.
• Cervical cancer ranks as the 1st most frequent cancer among
women in Tanzania, and the 1st most frequent cancer among
women between 15 and 44 years of age
Projections
• Projected number of new cervical cancer cases in
2025* is estimated to increases to 10257
• Projected number of cervical cancer deaths in
2025* is estimated to increase to 7173
Cervical cancer is on the increase
Pathogenesis
Cancer of the cervix has been regarded as a preventable
cancer because;
1. Known etiology. (HPV)
2. It has a long pre-invasive state.
3. Cervical cytological screening programs are available
4. Treatment of pre-invasive lesions is effective.
• Invasive cervical cancers are usually preceded by a
long phase of preinvasive disease.
• This is characterized microscopically as a
spectrum of events progressing from cellular
atypia to various grades of dysplasia or cervical
intraepithelial neoplasia (CIN) before progression
to invasive carcinoma
A good knowledge of the etiology, pathophysiology
and natural history of these pre-invasive conditions
provides a strong basis both for visual testing and
for colposcopic diagnosis and understanding the
principles of treatment of these lesions.
• CIN and cancer of cervix is a single, continuous disease
process by which normal epithelium evolves into
epithelial precursor lesions and on to invasive cancer.
• Precancerous lesions are usually discovered by a
screening test, the Papanicolaou or "pap" smear
Grades of CIN
(pre-invasive cancer)
CIN1 (Grade I)
• The least risky type, represents only mild dysplasia, or
abnormal cell growth and corresponds to a low grade
squamous intraepithelial lesion (LGSIL)..
• It is confined to the basal 1/3 of the epithelium.
• This corresponds to infection with HPV, and mostly will
be cleared by immune response in a year or so, though
can take several years to clear.
• as well as CIN III, correspond to high
grade squamous intraepithelial
lesions (HGSIL). CIN2 represents
moderate dysplasia, and is confined
to the basal 2/3 of the epithelium.
CIN2 (Grade II)
CIN3 (Grade III):
In this lesion, severe dysplasia spans
greater than 2/3 of the entire epithelium,
and may involve the full thickness. This
lesion may sometimes also be referred to
as cervical carcinoma in situ.
Disease Progression
The course of a specific lesion is influenced by;
1. Inciting HPV type.
2. Patients immune status
3. Smoking habits.
4. Time/duration
Disease Progression
CIN I CIN II CIN III
Regression to normal 60% 40% 30%
Persistence 30% 35% 48%
Progression to CIN III 10% 20% -
Progression to cancer <1% 5% 22%
Disease Progression
• However most CIN spontaneously regress.
• Progression to cancer typically takes 15 (3 to 40) years
• Also, evidence suggests that cancer can occur without
first detectably progressing through these stages and
that a high grade intraepithelial neoplasia can occur
without first existing as a lower grade.
Etiology
Epidemiological studies have identified a number of risk factors
that contribute to the development of cervical cancer
precursors and cervical cancer
• infection with certain oncogenic types of human
papillomaviruses (HPV),
• sexual intercourse at an early age,
• multiple sexual partners
• long-term oral contraceptive use,
• tobacco smoking
• low socioeconomic status
• multiparity
• micronutrient deficiency
• diet deficient in vegetables and fruits.
• Persistent infection with one or more of the
oncogenic types of HPV is considered to be a
necessary cause for cervical neoplasia.
• HPV infection is transmitted through sexual contact
and the risk factors therefore are closely related to
sexual behaviour (e.g., lifetime number of sexual
partners, sexual intercourse at an early age).
• HPV infection is believed to start in the basal
cells or parabasal cells of the metaplastic
epithelium
• Typically the disease starts at the squamo-
columna junction or transformation zone
• If the infection persists, integration of viral
genome into the host cellular genome occur.
• The normal differentiation and maturation of the immature
squamous metaplastic into the mature squamous
metaplastic epithelium may be disrupted as a result of
expression of E6/E7 viral oncoproteins and the loss of
normal growth control
• E6 and E7 have the ability to complex with the tumor
suppressor genes p53 and Rb, respectively
• This may then lead to development of abnormal dysplastic
epithelium
• If the neoplastic process continues uninterrupted, the
early low-grade lesions may eventually involve the full
thickness of the epithelium.
• Subsequently the disease may traverse the basement
membrane and become invasive cancer, extending to
surrounding tissues and organs
• Despite women’s frequent exposure to HPV,
development of cervical neoplasia is
uncommon
• Most cervical abnormalities caused by HPV
infection are unlikely to progress to high-
grade CIN or cervical cancer, as most of
them regress by themselves
Cell cycle
Etiology
The long time frame between initial infection and overt
disease indicates that several cofactors (e.g., genetic
differences, hormonal effects, micronutrient deficiencies,
smoking, or chronic inflammation) may be necessary for
disease progression.
• Immune system?
There are > 70 HPV subtypes, half of which infect
the ano-genital epithelium based on their
malignant potential, HPV subtypes are classified
as
• high risk,
• intermediate risk and
• low risk subtypes
• Low risk HPV (6,11,42,43,55) are associated with
condylomata and low grade pre-malignant
lesions of the cervix
• Intermediate risk HPV (33,35,51,520 are
associated with high grade lesion of the cervix.
• High risk HPV (16,18,31,39,45,57,58,59,68) are
associated with high grade lesions and invasive
cancer of the cervix.
• Cigarette smoking and HPV act synergistically on the
development of CIN.
• Cigarette smoking is associated with two to four fold
increase in relative risk for development of cervical
Cancer.
• Cigarette smoke carcinogens have been found to accumulate
locally in the cervical mucus and cumulative exposure as
measured by pack-year smoked is related to the risk of
developing CIN or carcinoma insitu.
• Incidence of cervical neoplasia is increased in HIV
infected women
Treatment of pre-invasive lesions (CIN)
• Cryotherapy
Nitrous oxide or carbon dioxide is used as the refrigerant for a
super-cooled probe
The cryoprobe is positioned on the ectocervix where it must cover
the entire lesion, which at times is not easily achieved. It is then
activated until blanching of the cervix extends at least 7 mm
beyond the probe in all directions in order to assure that freezing
extends beyond the depth of the crypts of the glands into which
the dysplasia might be extending.
Carbon Dioxide Laser
The laser destroys tissue with a very narrow zone of
injury around the treated tissue, and is therefore both
precise and flexible.
The tissue is vaporized to a depth of at least 7 mm to
assure that the bases of the deepest glands are
destroyed
• Loop Electrosurgical Excision Procedure (LEEP)
LEEP uses a small, fine, wire loop attached to an
electrosurgical generator to excise the tissue of interest.
Various sizes of wire loop are available
Following LEEP excision of the transformation zone,
frequently an additional narrow endocervical specimen is
removed to allow for histologic evaluation while avoiding
excessive damage to the cervical stroma
• Cold Knife Conization
Cold knife conization of the cervix refers to the excision of a
cone-shaped portion of the cervix using a scalpel. This
technique can be individualized to accommodate the
cervical anatomy and the size and shape of the lesion
Cervical cone biopsy is generally done in the operating
room under local or general anesthesia. Complications
include bleeding, infection, cervical stenosis, and cervical
incompetence
• Hysterectomy
Removal of the whole uterus with or without pelvic lymph
node dissection
CERVICAL CANCER:
Invasive cancer
• Age of incidence: Used to be a disease of old women but
nowadays the age of onset has decreased significantly.
• The average age at diagnosis of patients with cervical cancer is 51
years. However, the disease can occur in the second decade of life
• 75% decrease in the incidence of cervical cancer in developed
countries following the implementation of population-based
screening programs and treatment of preinvasive disease
• But the disease is on the increase in developing
countries
No active screening programs
Few treatment option
• Most patients In sub-Saharan Countries and
Tanzania is number 2 after Zambia
Histological types
• 70–75% of cervical carcinomas are squamous
cell (squamous cell carcinoma-SCC)
• adenocarcinomas (20–25%),
• adenosquamous carcinomas (3–5%),
Symptoms and Signs
• Abnormal vaginal bleeding is the most common symptom of
invasive cancer and may take the form of a blood-stained
leukorrheal discharge, scant spotting, or frank bleeding.
Leukorrhea, usually sanguineous or purulent, odorous, and
nonpruritic, is frequently present.
• A history of postcoital/contact bleeding may be elicited on
specific questioning.
• Pelvic pain, often unilateral and radiating to the hip or
thigh, is a manifestation of advanced disease.
• Also, as is the involuntary loss of urine or feces through
the vagina, a sign of fistula formation.
• Weakness, weight loss, and anemia are characteristic of
the late stages of the disease, although acute blood loss
and anemia may occur in an ulcerating stage I lesion.
Physical examination
• Speculum examination: Infiltrative cancer produces
enlargement, irregularity, and a firm consistency of the cervix
and eventually of the adjacent parametria.
• The growth pattern can be endophytic, leading to a barrel-
shaped enlargement of the cervix, or exophytic, where the
lesion generally appears as a friable, bleeding, cauliflower
like lesion of the portio vaginalis.
• Ulceration on the cervix may be the
primary manifestation of invasive
carcinoma;
• With further progression of the disease,
the ulcer becomes deeper and necrotic
• The adjacent vaginal fornices may become
involved next. Eventually, extensive
parametrial involvement by the infiltrative
process may produce a nodular thickening of
the uterosacral and cardinal ligaments with
resultant loss of mobility and fixation of the
cervix.
Definitive diagnosis
Biopsy for
histological
examination
Radiological exams
•Ultrasound
•IVU
•CXR
Laboratory tests
• Blood test
CBC
RFT
• Urine tests
urinalysis
Cervical cancer staging
• Stage 0 (CIN III) = carcinoma in situ
• Stage 1A = Microinvasive carcinoma
• Stage 1B = cancer confined to the cervix
• Stage 2A = cancer extend to the upper third of the
vagina
• Stage 2B = cancer extend to the parametrium but not to
the pelvic side walls
• Stage 3A = cancer involving the lower third of the
vagina
• Stage 3B = cancer extends to the pelvic side walls
(often obstructing the ureter)
• Stage 4A = cancer involving the bladder and/or
rectum
• Stage 4B = Distant metastasis
Treatment of cervical cancer
• Surgical approach: For very early cervical cancer (1A)
Hysterectomy plus lymph node dissection
• Main stay is Radiotherapy with chemotherapy (Cisplatin IV)
External beam followed by intracavitary
PREVENTION OF CERVICAL CANCER
1. Cervical cancer screening to detect premalignant
conditions
Visual inspection of the cervix (Speculum) with
acetic acid or Iodine = Acetowhite changes
Pap smears
Colposcopy and Biopsy
2. Vaccine for HPV to all women before they are infected
(Before they start sexual activity)
Young girls are the major target but any woman 10-50 can
receive the vaccine
3. Sexual behavior
Late onset of sex
Number and behavior of sexual partners
Male circumscion
4. Using barrier methods
Male condoms
Female condom
Cervical cancer

More Related Content

What's hot

Presentation on cervical cancer
Presentation on cervical cancerPresentation on cervical cancer
Presentation on cervical cancerlok kathayat
 
Vaginal Cancer
Vaginal CancerVaginal Cancer
Vaginal Cancerfitango
 
Management of endometrial carcinoma
Management of endometrial carcinomaManagement of endometrial carcinoma
Management of endometrial carcinomaSailendra Parida
 
Cervical Cancer Prevention UPDATE ON H.P.V. vaccination
Cervical Cancer Prevention UPDATE ON H.P.V. vaccinationCervical Cancer Prevention UPDATE ON H.P.V. vaccination
Cervical Cancer Prevention UPDATE ON H.P.V. vaccinationNavneet Upadhyay
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancerdrizsyed
 
Carcinoma Cervix
Carcinoma CervixCarcinoma Cervix
Carcinoma Cervixdrmcbansal
 
Chemotherapy in gynaecological malignancies
Chemotherapy in gynaecological malignanciesChemotherapy in gynaecological malignancies
Chemotherapy in gynaecological malignanciesdrmcbansal
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancerJwanSalh
 
Endometrial carcinoma
Endometrial carcinomaEndometrial carcinoma
Endometrial carcinomaobgymgmcri
 
Breast Cancer Awareness Presentation
Breast Cancer Awareness Presentation Breast Cancer Awareness Presentation
Breast Cancer Awareness Presentation RacDokki
 

What's hot (20)

Cervix cancer
Cervix cancerCervix cancer
Cervix cancer
 
Endometrial Carcinoma
Endometrial Carcinoma Endometrial Carcinoma
Endometrial Carcinoma
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Presentation on cervical cancer
Presentation on cervical cancerPresentation on cervical cancer
Presentation on cervical cancer
 
Vaginal Cancer
Vaginal CancerVaginal Cancer
Vaginal Cancer
 
Management of endometrial carcinoma
Management of endometrial carcinomaManagement of endometrial carcinoma
Management of endometrial carcinoma
 
ENDOMETRIAL CANCER
ENDOMETRIAL CANCERENDOMETRIAL CANCER
ENDOMETRIAL CANCER
 
Cervical Cancer Prevention UPDATE ON H.P.V. vaccination
Cervical Cancer Prevention UPDATE ON H.P.V. vaccinationCervical Cancer Prevention UPDATE ON H.P.V. vaccination
Cervical Cancer Prevention UPDATE ON H.P.V. vaccination
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Carcinoma Cervix
Carcinoma CervixCarcinoma Cervix
Carcinoma Cervix
 
Chemotherapy in gynaecological malignancies
Chemotherapy in gynaecological malignanciesChemotherapy in gynaecological malignancies
Chemotherapy in gynaecological malignancies
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Endometrial Carcinoma
Endometrial CarcinomaEndometrial Carcinoma
Endometrial Carcinoma
 
Endometrial carcinoma
Endometrial carcinomaEndometrial carcinoma
Endometrial carcinoma
 
Breast Cancer Awareness Presentation
Breast Cancer Awareness Presentation Breast Cancer Awareness Presentation
Breast Cancer Awareness Presentation
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Endometrial carcinoma - SSJ,CALICUT MEDICAL COLLEGE
Endometrial carcinoma - SSJ,CALICUT MEDICAL COLLEGEEndometrial carcinoma - SSJ,CALICUT MEDICAL COLLEGE
Endometrial carcinoma - SSJ,CALICUT MEDICAL COLLEGE
 
Vulval cancer
Vulval cancerVulval cancer
Vulval cancer
 
Cancer cervix
Cancer cervixCancer cervix
Cancer cervix
 

Viewers also liked

Cervical Cancer Awareness
Cervical Cancer AwarenessCervical Cancer Awareness
Cervical Cancer Awarenessdharshinee-shri
 
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comCervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comjinekolojivegebelik.com
 
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...Theresa Lowry-Lehnen
 
Epidemiology of oral and cervical cancer
Epidemiology of oral  and cervical  cancerEpidemiology of oral  and cervical  cancer
Epidemiology of oral and cervical cancerSrinivasan Gunasekaran
 
Doc seminar cervical cancer
Doc seminar cervical cancerDoc seminar cervical cancer
Doc seminar cervical cancerDUVASU
 
Screening for cervical cancer
Screening for  cervical cancerScreening for  cervical cancer
Screening for cervical cancerAboubakr Elnashar
 
Cervical Cancer Educational Presentation
Cervical Cancer Educational PresentationCervical Cancer Educational Presentation
Cervical Cancer Educational Presentationrinki singh
 
Cancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCTCancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCTSheh Rawat
 
Cancer de cervix grethel garcia
Cancer de cervix grethel garciaCancer de cervix grethel garcia
Cancer de cervix grethel garciaGrethel Gc
 
Frontline Cervical Cancer Prevention Approach: Via and Cryotheraphy in One Vi...
Frontline Cervical Cancer Prevention Approach: Via and Cryotheraphy in One Vi...Frontline Cervical Cancer Prevention Approach: Via and Cryotheraphy in One Vi...
Frontline Cervical Cancer Prevention Approach: Via and Cryotheraphy in One Vi...CORE Group
 
Fertility preservation in Cancer Cervix
Fertility preservation in Cancer CervixFertility preservation in Cancer Cervix
Fertility preservation in Cancer CervixSujoy Dasgupta
 
Premalignantcx lecture (1)
Premalignantcx lecture (1)Premalignantcx lecture (1)
Premalignantcx lecture (1)s_thunga
 
Cervical Cancer and HPV by CANSA
Cervical Cancer and HPV by CANSACervical Cancer and HPV by CANSA
Cervical Cancer and HPV by CANSADES Daughter
 
Simon Leeson - Colposcopic treatment standards
Simon Leeson - Colposcopic treatment standardsSimon Leeson - Colposcopic treatment standards
Simon Leeson - Colposcopic treatment standardstriumphbenelux
 

Viewers also liked (20)

Cervical cancer ppt
Cervical cancer pptCervical cancer ppt
Cervical cancer ppt
 
Cervical Cancer Awareness
Cervical Cancer AwarenessCervical Cancer Awareness
Cervical Cancer Awareness
 
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comCervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
 
Cervical cancer
Cervical  cancerCervical  cancer
Cervical cancer
 
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...
Cervical Cancer. The Importance of Cervical Screening and Vaccination Program...
 
Epidemiology of oral and cervical cancer
Epidemiology of oral  and cervical  cancerEpidemiology of oral  and cervical  cancer
Epidemiology of oral and cervical cancer
 
Doc seminar cervical cancer
Doc seminar cervical cancerDoc seminar cervical cancer
Doc seminar cervical cancer
 
Screening for cervical cancer
Screening for  cervical cancerScreening for  cervical cancer
Screening for cervical cancer
 
Cervical Cancer
Cervical CancerCervical Cancer
Cervical Cancer
 
Cervical Cancer Educational Presentation
Cervical Cancer Educational PresentationCervical Cancer Educational Presentation
Cervical Cancer Educational Presentation
 
prevention Cervical cancer
prevention Cervical cancerprevention Cervical cancer
prevention Cervical cancer
 
Cancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCTCancer Cervix- NACT vs RT+CCT
Cancer Cervix- NACT vs RT+CCT
 
Notes ca cervix pdf
Notes ca cervix pdfNotes ca cervix pdf
Notes ca cervix pdf
 
Cancer de cervix grethel garcia
Cancer de cervix grethel garciaCancer de cervix grethel garcia
Cancer de cervix grethel garcia
 
Gyaenocological examination 2
Gyaenocological examination 2Gyaenocological examination 2
Gyaenocological examination 2
 
Frontline Cervical Cancer Prevention Approach: Via and Cryotheraphy in One Vi...
Frontline Cervical Cancer Prevention Approach: Via and Cryotheraphy in One Vi...Frontline Cervical Cancer Prevention Approach: Via and Cryotheraphy in One Vi...
Frontline Cervical Cancer Prevention Approach: Via and Cryotheraphy in One Vi...
 
Fertility preservation in Cancer Cervix
Fertility preservation in Cancer CervixFertility preservation in Cancer Cervix
Fertility preservation in Cancer Cervix
 
Premalignantcx lecture (1)
Premalignantcx lecture (1)Premalignantcx lecture (1)
Premalignantcx lecture (1)
 
Cervical Cancer and HPV by CANSA
Cervical Cancer and HPV by CANSACervical Cancer and HPV by CANSA
Cervical Cancer and HPV by CANSA
 
Simon Leeson - Colposcopic treatment standards
Simon Leeson - Colposcopic treatment standardsSimon Leeson - Colposcopic treatment standards
Simon Leeson - Colposcopic treatment standards
 

Similar to Cervical cancer

premalignant lesions of cervix.pptx
premalignant  lesions of cervix.pptxpremalignant  lesions of cervix.pptx
premalignant lesions of cervix.pptxsarath267362
 
CERVICAL CANCER-1.pptx
CERVICAL CANCER-1.pptxCERVICAL CANCER-1.pptx
CERVICAL CANCER-1.pptxLivinusmukana
 
Carcinoma Cervix.pptx
Carcinoma Cervix.pptxCarcinoma Cervix.pptx
Carcinoma Cervix.pptxAeyshaBegum
 
CIN and Cervical Screening
CIN and Cervical ScreeningCIN and Cervical Screening
CIN and Cervical ScreeningPro Faather
 
Etiopathogenesis and natural history of ca cervix
Etiopathogenesis and natural history of ca cervixEtiopathogenesis and natural history of ca cervix
Etiopathogenesis and natural history of ca cervixNiranjan Chavan
 
Etiopathogenesis and natural history of ca cervix
Etiopathogenesis and natural history of ca cervixEtiopathogenesis and natural history of ca cervix
Etiopathogenesis and natural history of ca cervixNiranjan Chavan
 
Cancer of Cervix
Cancer of CervixCancer of Cervix
Cancer of CervixAli Alavi
 
Penile carcinoma basic sience
Penile carcinoma basic siencePenile carcinoma basic sience
Penile carcinoma basic siencedamuluri ramu
 
invasise Cervical carcinoma
invasise Cervical carcinomainvasise Cervical carcinoma
invasise Cervical carcinomaAisha Nazeer
 
Cevical intraepithelial neoplasia & screening ppt
Cevical intraepithelial neoplasia & screening  pptCevical intraepithelial neoplasia & screening  ppt
Cevical intraepithelial neoplasia & screening pptDr H.K. Cheema
 
CERVICAL CANCER presentation for the clinic
CERVICAL CANCER presentation for the clinicCERVICAL CANCER presentation for the clinic
CERVICAL CANCER presentation for the clinicShadreckChipapi1
 

Similar to Cervical cancer (20)

Ca cervix pre managment
Ca cervix pre managmentCa cervix pre managment
Ca cervix pre managment
 
Cervix - 2nd year UG
Cervix - 2nd year UGCervix - 2nd year UG
Cervix - 2nd year UG
 
Cervical carcinoma
Cervical carcinomaCervical carcinoma
Cervical carcinoma
 
premalignant lesions of cervix.pptx
premalignant  lesions of cervix.pptxpremalignant  lesions of cervix.pptx
premalignant lesions of cervix.pptx
 
CERVICAL CANCER-1.pptx
CERVICAL CANCER-1.pptxCERVICAL CANCER-1.pptx
CERVICAL CANCER-1.pptx
 
Carcinoma Cervix.pptx
Carcinoma Cervix.pptxCarcinoma Cervix.pptx
Carcinoma Cervix.pptx
 
Cervical ca prevention
Cervical ca preventionCervical ca prevention
Cervical ca prevention
 
CIN and Cervical Screening
CIN and Cervical ScreeningCIN and Cervical Screening
CIN and Cervical Screening
 
Etiopathogenesis and natural history of ca cervix
Etiopathogenesis and natural history of ca cervixEtiopathogenesis and natural history of ca cervix
Etiopathogenesis and natural history of ca cervix
 
Etiopathogenesis and natural history of ca cervix
Etiopathogenesis and natural history of ca cervixEtiopathogenesis and natural history of ca cervix
Etiopathogenesis and natural history of ca cervix
 
cervical cancer.pptx
cervical cancer.pptxcervical cancer.pptx
cervical cancer.pptx
 
Cancer of Cervix
Cancer of CervixCancer of Cervix
Cancer of Cervix
 
Penile carcinoma basic sience
Penile carcinoma basic siencePenile carcinoma basic sience
Penile carcinoma basic sience
 
invasise Cervical carcinoma
invasise Cervical carcinomainvasise Cervical carcinoma
invasise Cervical carcinoma
 
ca cervix.pdf
ca cervix.pdfca cervix.pdf
ca cervix.pdf
 
Cevical intraepithelial neoplasia & screening ppt
Cevical intraepithelial neoplasia & screening  pptCevical intraepithelial neoplasia & screening  ppt
Cevical intraepithelial neoplasia & screening ppt
 
Ca cervix
Ca cervixCa cervix
Ca cervix
 
screening.pptx
screening.pptxscreening.pptx
screening.pptx
 
Carcinoma penis
Carcinoma penisCarcinoma penis
Carcinoma penis
 
CERVICAL CANCER presentation for the clinic
CERVICAL CANCER presentation for the clinicCERVICAL CANCER presentation for the clinic
CERVICAL CANCER presentation for the clinic
 

More from Fahad Zakwan (20)

Version
VersionVersion
Version
 
Us in obstretics
Us in obstreticsUs in obstretics
Us in obstretics
 
Rupture of the uterus
Rupture of the uterusRupture of the uterus
Rupture of the uterus
 
Rpl
RplRpl
Rpl
 
Pueperium
PueperiumPueperium
Pueperium
 
Pueperal sepsis
Pueperal sepsisPueperal sepsis
Pueperal sepsis
 
Ptl
PtlPtl
Ptl
 
Prom
PromProm
Prom
 
Prolonged labour
Prolonged labourProlonged labour
Prolonged labour
 
Pph
PphPph
Pph
 
Placenta praevia
Placenta praeviaPlacenta praevia
Placenta praevia
 
Pih
PihPih
Pih
 
Pid
PidPid
Pid
 
Ovarian tumors
Ovarian tumorsOvarian tumors
Ovarian tumors
 
Ovarian cysts
Ovarian cystsOvarian cysts
Ovarian cysts
 
Obtetrics terms
Obtetrics termsObtetrics terms
Obtetrics terms
 
Multiple pregnancy
Multiple pregnancyMultiple pregnancy
Multiple pregnancy
 
Malaria in prgnancy
Malaria in prgnancyMalaria in prgnancy
Malaria in prgnancy
 
Labour and delivery
Labour and deliveryLabour and delivery
Labour and delivery
 
Iugr
IugrIugr
Iugr
 

Cervical cancer

  • 3. Epidemiology • Cancer of the cervix uteri is the second most common cancer among women worldwide BUT • for Tanzania is the leading type of cancer in women and the commonest cause of cancer related deaths in this country.
  • 4. Burden in Tanzania • Tanzania has a population of 10.97 millions women ages 15 years and older who are at risk of developing cervical cancer. • Current estimates indicate that every year 6241 women are diagnosed with cervical cancer and 4355 die from the disease. • Cervical cancer ranks as the 1st most frequent cancer among women in Tanzania, and the 1st most frequent cancer among women between 15 and 44 years of age
  • 5. Projections • Projected number of new cervical cancer cases in 2025* is estimated to increases to 10257 • Projected number of cervical cancer deaths in 2025* is estimated to increase to 7173 Cervical cancer is on the increase
  • 6. Pathogenesis Cancer of the cervix has been regarded as a preventable cancer because; 1. Known etiology. (HPV) 2. It has a long pre-invasive state. 3. Cervical cytological screening programs are available 4. Treatment of pre-invasive lesions is effective.
  • 7. • Invasive cervical cancers are usually preceded by a long phase of preinvasive disease. • This is characterized microscopically as a spectrum of events progressing from cellular atypia to various grades of dysplasia or cervical intraepithelial neoplasia (CIN) before progression to invasive carcinoma
  • 8. A good knowledge of the etiology, pathophysiology and natural history of these pre-invasive conditions provides a strong basis both for visual testing and for colposcopic diagnosis and understanding the principles of treatment of these lesions.
  • 9. • CIN and cancer of cervix is a single, continuous disease process by which normal epithelium evolves into epithelial precursor lesions and on to invasive cancer. • Precancerous lesions are usually discovered by a screening test, the Papanicolaou or "pap" smear
  • 10.
  • 11. Grades of CIN (pre-invasive cancer) CIN1 (Grade I) • The least risky type, represents only mild dysplasia, or abnormal cell growth and corresponds to a low grade squamous intraepithelial lesion (LGSIL).. • It is confined to the basal 1/3 of the epithelium. • This corresponds to infection with HPV, and mostly will be cleared by immune response in a year or so, though can take several years to clear.
  • 12. • as well as CIN III, correspond to high grade squamous intraepithelial lesions (HGSIL). CIN2 represents moderate dysplasia, and is confined to the basal 2/3 of the epithelium. CIN2 (Grade II)
  • 13. CIN3 (Grade III): In this lesion, severe dysplasia spans greater than 2/3 of the entire epithelium, and may involve the full thickness. This lesion may sometimes also be referred to as cervical carcinoma in situ.
  • 14. Disease Progression The course of a specific lesion is influenced by; 1. Inciting HPV type. 2. Patients immune status 3. Smoking habits. 4. Time/duration
  • 15. Disease Progression CIN I CIN II CIN III Regression to normal 60% 40% 30% Persistence 30% 35% 48% Progression to CIN III 10% 20% - Progression to cancer <1% 5% 22%
  • 16. Disease Progression • However most CIN spontaneously regress. • Progression to cancer typically takes 15 (3 to 40) years • Also, evidence suggests that cancer can occur without first detectably progressing through these stages and that a high grade intraepithelial neoplasia can occur without first existing as a lower grade.
  • 17. Etiology Epidemiological studies have identified a number of risk factors that contribute to the development of cervical cancer precursors and cervical cancer • infection with certain oncogenic types of human papillomaviruses (HPV), • sexual intercourse at an early age, • multiple sexual partners
  • 18. • long-term oral contraceptive use, • tobacco smoking • low socioeconomic status • multiparity • micronutrient deficiency • diet deficient in vegetables and fruits.
  • 19. • Persistent infection with one or more of the oncogenic types of HPV is considered to be a necessary cause for cervical neoplasia. • HPV infection is transmitted through sexual contact and the risk factors therefore are closely related to sexual behaviour (e.g., lifetime number of sexual partners, sexual intercourse at an early age).
  • 20. • HPV infection is believed to start in the basal cells or parabasal cells of the metaplastic epithelium • Typically the disease starts at the squamo- columna junction or transformation zone • If the infection persists, integration of viral genome into the host cellular genome occur.
  • 21. • The normal differentiation and maturation of the immature squamous metaplastic into the mature squamous metaplastic epithelium may be disrupted as a result of expression of E6/E7 viral oncoproteins and the loss of normal growth control • E6 and E7 have the ability to complex with the tumor suppressor genes p53 and Rb, respectively • This may then lead to development of abnormal dysplastic epithelium
  • 22. • If the neoplastic process continues uninterrupted, the early low-grade lesions may eventually involve the full thickness of the epithelium. • Subsequently the disease may traverse the basement membrane and become invasive cancer, extending to surrounding tissues and organs
  • 23. • Despite women’s frequent exposure to HPV, development of cervical neoplasia is uncommon • Most cervical abnormalities caused by HPV infection are unlikely to progress to high- grade CIN or cervical cancer, as most of them regress by themselves
  • 25. Etiology The long time frame between initial infection and overt disease indicates that several cofactors (e.g., genetic differences, hormonal effects, micronutrient deficiencies, smoking, or chronic inflammation) may be necessary for disease progression. • Immune system?
  • 26. There are > 70 HPV subtypes, half of which infect the ano-genital epithelium based on their malignant potential, HPV subtypes are classified as • high risk, • intermediate risk and • low risk subtypes
  • 27. • Low risk HPV (6,11,42,43,55) are associated with condylomata and low grade pre-malignant lesions of the cervix • Intermediate risk HPV (33,35,51,520 are associated with high grade lesion of the cervix. • High risk HPV (16,18,31,39,45,57,58,59,68) are associated with high grade lesions and invasive cancer of the cervix.
  • 28. • Cigarette smoking and HPV act synergistically on the development of CIN. • Cigarette smoking is associated with two to four fold increase in relative risk for development of cervical Cancer. • Cigarette smoke carcinogens have been found to accumulate locally in the cervical mucus and cumulative exposure as measured by pack-year smoked is related to the risk of developing CIN or carcinoma insitu. • Incidence of cervical neoplasia is increased in HIV infected women
  • 29. Treatment of pre-invasive lesions (CIN) • Cryotherapy Nitrous oxide or carbon dioxide is used as the refrigerant for a super-cooled probe The cryoprobe is positioned on the ectocervix where it must cover the entire lesion, which at times is not easily achieved. It is then activated until blanching of the cervix extends at least 7 mm beyond the probe in all directions in order to assure that freezing extends beyond the depth of the crypts of the glands into which the dysplasia might be extending.
  • 30. Carbon Dioxide Laser The laser destroys tissue with a very narrow zone of injury around the treated tissue, and is therefore both precise and flexible. The tissue is vaporized to a depth of at least 7 mm to assure that the bases of the deepest glands are destroyed
  • 31. • Loop Electrosurgical Excision Procedure (LEEP) LEEP uses a small, fine, wire loop attached to an electrosurgical generator to excise the tissue of interest. Various sizes of wire loop are available Following LEEP excision of the transformation zone, frequently an additional narrow endocervical specimen is removed to allow for histologic evaluation while avoiding excessive damage to the cervical stroma
  • 32. • Cold Knife Conization Cold knife conization of the cervix refers to the excision of a cone-shaped portion of the cervix using a scalpel. This technique can be individualized to accommodate the cervical anatomy and the size and shape of the lesion Cervical cone biopsy is generally done in the operating room under local or general anesthesia. Complications include bleeding, infection, cervical stenosis, and cervical incompetence
  • 33. • Hysterectomy Removal of the whole uterus with or without pelvic lymph node dissection
  • 34. CERVICAL CANCER: Invasive cancer • Age of incidence: Used to be a disease of old women but nowadays the age of onset has decreased significantly. • The average age at diagnosis of patients with cervical cancer is 51 years. However, the disease can occur in the second decade of life • 75% decrease in the incidence of cervical cancer in developed countries following the implementation of population-based screening programs and treatment of preinvasive disease
  • 35. • But the disease is on the increase in developing countries No active screening programs Few treatment option • Most patients In sub-Saharan Countries and Tanzania is number 2 after Zambia
  • 36. Histological types • 70–75% of cervical carcinomas are squamous cell (squamous cell carcinoma-SCC) • adenocarcinomas (20–25%), • adenosquamous carcinomas (3–5%),
  • 37. Symptoms and Signs • Abnormal vaginal bleeding is the most common symptom of invasive cancer and may take the form of a blood-stained leukorrheal discharge, scant spotting, or frank bleeding. Leukorrhea, usually sanguineous or purulent, odorous, and nonpruritic, is frequently present. • A history of postcoital/contact bleeding may be elicited on specific questioning.
  • 38. • Pelvic pain, often unilateral and radiating to the hip or thigh, is a manifestation of advanced disease. • Also, as is the involuntary loss of urine or feces through the vagina, a sign of fistula formation. • Weakness, weight loss, and anemia are characteristic of the late stages of the disease, although acute blood loss and anemia may occur in an ulcerating stage I lesion.
  • 39. Physical examination • Speculum examination: Infiltrative cancer produces enlargement, irregularity, and a firm consistency of the cervix and eventually of the adjacent parametria. • The growth pattern can be endophytic, leading to a barrel- shaped enlargement of the cervix, or exophytic, where the lesion generally appears as a friable, bleeding, cauliflower like lesion of the portio vaginalis.
  • 40. • Ulceration on the cervix may be the primary manifestation of invasive carcinoma; • With further progression of the disease, the ulcer becomes deeper and necrotic
  • 41. • The adjacent vaginal fornices may become involved next. Eventually, extensive parametrial involvement by the infiltrative process may produce a nodular thickening of the uterosacral and cardinal ligaments with resultant loss of mobility and fixation of the cervix.
  • 42.
  • 45. Laboratory tests • Blood test CBC RFT • Urine tests urinalysis
  • 46. Cervical cancer staging • Stage 0 (CIN III) = carcinoma in situ • Stage 1A = Microinvasive carcinoma • Stage 1B = cancer confined to the cervix • Stage 2A = cancer extend to the upper third of the vagina • Stage 2B = cancer extend to the parametrium but not to the pelvic side walls
  • 47.
  • 48. • Stage 3A = cancer involving the lower third of the vagina • Stage 3B = cancer extends to the pelvic side walls (often obstructing the ureter) • Stage 4A = cancer involving the bladder and/or rectum • Stage 4B = Distant metastasis
  • 49. Treatment of cervical cancer • Surgical approach: For very early cervical cancer (1A) Hysterectomy plus lymph node dissection • Main stay is Radiotherapy with chemotherapy (Cisplatin IV) External beam followed by intracavitary
  • 50. PREVENTION OF CERVICAL CANCER 1. Cervical cancer screening to detect premalignant conditions Visual inspection of the cervix (Speculum) with acetic acid or Iodine = Acetowhite changes Pap smears Colposcopy and Biopsy
  • 51. 2. Vaccine for HPV to all women before they are infected (Before they start sexual activity) Young girls are the major target but any woman 10-50 can receive the vaccine 3. Sexual behavior Late onset of sex Number and behavior of sexual partners Male circumscion
  • 52. 4. Using barrier methods Male condoms Female condom